GlassScriptPhysician profile
Noah Kirshner
NPI 1679143036
$8,795.72
in general payments reported to CMS, 2019-2025
17 companies · $3,818 in 2025
The $3,818 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $528 · 2022: $1,309 · 2023: $770 · 2024: $2,370 · 2025: $3,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,251 · Food and Beverage: $2,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,251.48 |
| Food and Beverage | $2,707.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,364.37 | 2022-2025 | Hoffmann, Ortholoc 3di, Inspace |
| Arthrex, INC. | $1,257.78 | 2025 | |
| Vilex LLC | $1,172.99 | 2024 | |
| Paragon 28, INC. | $980.00 | 2022-2025 | Portfolio, Trauma |
| Smith+Nephew, INC. | $529.00 | 2021-2023 | Versajet |
| Integra Lifesciences Corporation | $422.15 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $272.01 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $144.54 | 2021-2024 | Nuzyra |
| Averitas Pharma INC. | $124.93 | 2023 | Qutenza |
| Organogenesis INC. | $123.60 | 2021 | |
| Heron Therapeutics, INC. | $104.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $90.94 | 2022 | |
| Grt US Holding, INC. | $80.28 | 2022 | |
| Abbvie INC. | $59.22 | 2023-2024 | |
| Bioventus LLC | $36.17 | 2023 | Exogen Ultrasound Bone Healing System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eclipse Technology Solutions INC. | $20.01 | 2025 | |
| Depuy Synthes Sales INC. | $13.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Kirshner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.